These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38282143)

  • 1. Identification and validation of non-coding RNA-mediated high expression of IQGAP3 in poor prognosis of lung adenocarcinoma.
    Su Z; Wang Y; Cao J; Ma J; Wang G; Ren H; Zhang Y; Sheng K; Zhu X; Wang Y
    J Gene Med; 2024 Jan; 26(1):e3664. PubMed ID: 38282143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC01089 suppresses lung adenocarcinoma cell proliferation and migration via miR-301b-3p/STARD13 axis.
    Qian Y; Zhang Y; Ji H; Shen Y; Zheng L; Cheng S; Lu X
    BMC Pulm Med; 2021 Jul; 21(1):242. PubMed ID: 34281560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis.
    Zhu C; Wang S; Zheng M; Chen Z; Wang G; Ma J; Zhang B; Huang W; Sun X; Wang C
    Strahlenther Onkol; 2022 Mar; 198(3):304-314. PubMed ID: 35037949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
    Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
    Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM36 enhances lung adenocarcinoma radiosensitivity and inhibits tumorigenesis through promoting RAD51 ubiquitination and antagonizing hsa-miR-376a-5p.
    Yu S; Li W; Liu X; Zhang H; Liu X; Zhang LW
    Biochem Biophys Res Commun; 2022 Nov; 628():1-10. PubMed ID: 36058131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
    Fu L; Li Z; Wu Y; Zhu T; Ma Z; Dong L; Ding J; Zhang C; Yu G
    Biochem Genet; 2023 Aug; 61(4):1528-1547. PubMed ID: 36658310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0070661 inhibits cancer progression through miR-556-5p/TEK axis in lung adenocarcinoma.
    Chen Y; Wu Y
    Cancer Biomark; 2023; 37(1):53-66. PubMed ID: 37005879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [miR-218-5p Targeting TPX2 Regulates p53 Pathway and Inhibits Malignant Progression of Lung Adenocarcinoma].
    Xu J
    Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):721-731. PubMed ID: 37989335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma.
    Zhou Q; Li D; Zheng H; He Z; Qian F; Wu X; Yin Z; Bao PT; Jin M
    Thorac Cancer; 2021 Oct; 12(19):2526-2536. PubMed ID: 34453499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of hsa_circ_0008274 inhibited the progression of lung adenocarcinoma by regulating HMGA2 via sponging miR-578.
    Wang M; Ma M; Yang Y; Li C; Wang Y; Sun X; Wang M; Sun Y; Jiao W
    Thorac Cancer; 2021 Aug; 12(16):2258-2264. PubMed ID: 34236145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identify miRNA-mRNA regulation pairs to explore potential pathogenesis of lung adenocarcinoma.
    Fan X; Zou X; Liu C; Peng S; Zhang S; Zhou X; Zhu J; Zhu W
    Aging (Albany NY); 2022 Oct; 14(20):8357-8373. PubMed ID: 36260870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance and mechanism of microRNA-22-3p targeting TP53 in lung adenocarcinoma.
    Lin R; Li GS; Gan XY; Peng JX; Feng Y; Wang LT; Zhang CY; Huang KY; Huang SH; Yang L; Kong JL; Zhou HF; Chen G; Huang WY
    Technol Health Care; 2023; 31(5):1691-1707. PubMed ID: 36970920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p.
    Dong HX; Wang R; Jin XY; Zeng J; Pan J
    J Cell Physiol; 2018 May; 233(5):4126-4136. PubMed ID: 29030962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-182-5p Serves as an Oncogene in Lung Adenocarcinoma through Binding to STARD13.
    Wu X; Wang W; Wu G; Peng C; Liu J
    Comput Math Methods Med; 2021; 2021():7074343. PubMed ID: 34335864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
    Liu T; Yang C; Wang W; Liu C
    Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an Exosome-relevant SNHG6-hsa-miR-429- CHRDL1/CCNA2 Axis for Lung Adenocarcinoma Prognosis Evaluation.
    Yuan Y; Li Q; Chen F; Zhao Y; Ma J; Fang S
    Curr Med Chem; 2024; 31(28):4549-4561. PubMed ID: 38994652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
    Zhu Y; Bo H; Chen Z; Li J; He D; Xiao M; Xiang L; Jin L; Zhou J; Gong L; Zhou Y; Zhou M; Xiong W; Xing X; Li R; Cao K
    Aging (Albany NY); 2020 Nov; 12(21):21904-21922. PubMed ID: 33147570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543.
    Xu Y; Lin L; Lv D; Yan S; He S; Ge H
    Tissue Cell; 2021 Oct; 72():101535. PubMed ID: 33892399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.